Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Discover a metal-free, high-yield method for chiral 1,3-diamine with >97:3 dr. Reduce costs and supply chain risks in pharmaceutical synthesis.
Solve supply chain risks with 90%+ yield 3-chloro-4-amino maleimide synthesis. Copper-catalyzed, oxygen-tolerant process eliminates expensive anhydrous equipment. Contact for custom manufacturing.
Discover how CO-free palladium-catalyzed synthesis of 2-trifluoromethyl quinazolinones reduces safety risks and costs for pharmaceutical intermediates. Scale-ready solution for R&D and procurement teams.
Solve CO toxicity risks in quinazolinone synthesis with this patent method. Achieve high yields, low costs, and scalable production for drug development.
Discover how photocatalytic N-alpha arylation eliminates HAT reagents, reduces costs, and achieves 99% purity for pharmaceutical intermediates. Scale to 100 MT/annual with CDMO expertise.
Discover how this dual-chiral ligand enables 91% ee in asymmetric reactions, reducing R&D costs and supply chain risks for pharmaceutical intermediates.
Solve high-toxicity metal cyanide issues in aryl acetonitrile production. Our catalyst-free method offers 91% yield, air-stable operation, and scalable manufacturing for drug development.
Solve supply chain risks with metal-free synthesis of brominated BCPs. High-yield, green process for drug development. Contact for custom synthesis.
Solve 6-substituted phenanthridine synthesis challenges with non-precious metal catalysis. 85% yield, mild conditions, and scalable production for pharma R&D and procurement.
Discover how visible light photocatalysis enables high-yield, metal-free synthesis of difluoromethyl aldehyde hydrazones, reducing costs and supply chain risks for pharmaceutical intermediates.
Solve aryl azide synthesis challenges with mild copper-catalyzed routes. 91% yield, no strong acid, and broad substrate scope for stable API production.
Solve metal residue issues in 3-thioindole production. 70% yield, no transition metals, room-temperature process. CDMO expertise for scalable API synthesis.
Discover how nitroarene-based reductive aminocarbonylation enables scalable, high-yield chroman amide production for pharmaceutical intermediates with 99%+ purity and reduced supply chain risks.
Eliminate hazardous azide handling in 1,2,3-triazole synthesis. Our CDMO expertise ensures high-yield, scalable production for drug development.
Solve low-yield challenges in C-3 benzyl indolizine production with this palladium-catalyzed method. Achieve 67% yield, simplified post-treatment, and scalable manufacturing for antitumor drug development.
Discover a novel chiral synthesis method for isopyrone-indole derivatives with 92% ee and 80% yield. Ideal for oncology drug development.
Solve pyrone synthesis challenges with new palladium-catalyzed method. Achieve high yields, broad functional group tolerance, and low-cost raw materials for pharmaceutical intermediates.
Discover how metal-free synthesis of benzofuran-3-oxocarboxylates reduces production costs by 30% while ensuring >99% purity. Ideal for API manufacturing.
Discover a scalable, metal-free synthesis for trifluoromethyl dihydrofuranamine with >99% purity. Reduce supply chain risks and accelerate drug development with our CDMO expertise.
Solve harsh reaction conditions and poor functional group tolerance in trifluoromethyl heterocycle synthesis. Our CDMO expertise ensures scalable, high-purity production for pharma intermediates.